Crimean-Congo hemorrhagic fever: An overview
- 641 Downloads
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic viral infection that is a serious threat to humans. The disease is widely distributed in Africa, Asia, and Europe and has developed into a serious public health concern. Humans become infected through the bites of ticks, by contact with a patient with CCHF, or by contact with blood or tissues from viremic livestock. Microvascular instability and impaired hemostasis are the hallmarks of the infection. Infection in human begins with nonspecific febrile symptoms, but may progress to a serious hemorrhagic syndrome with high mortality rates. Enzyme-linked immunoassay (ELISA) and polymerase chain reaction (PCR) are the most used and specific tests for the diagnosis. The mainstay of treatment is supportive. Although definitive studies are not available, ribavirin is suggested to be effective especially at the earlier phase of the infection. Uses of universal protective measures are the best way to avoid the infection. In this review, all aspects of CCHF are overviewed in light of the current literature.
KeywordsCrimean-Congo Hemorrhagic Fever Epidemiology Transmission Pathogenesis Diagnosis Treatment Prevention
Unable to display preview. Download preview PDF.
- Cherenov I V, Galimzianov K M, Sologub T V, Romantsov M G, Lokteva O M, and Kovalenko A L. 2012. Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever. Klin Med (Mosk), 90: 59–62.Google Scholar
- Drosten C, Gottig S, Schilling S, Asper M, Panning M, Schmitz H, and Gunther S. 2002. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol, 40: 2323–2330.PubMedCrossRefGoogle Scholar
- Elaldi N, Bodur H, Ascioglu S, Celikbas A, Ozkurt Z, Vahaboglu H, Leblebicioglu H, Yilmaz N, Engin A, Sencan M, Aydin K, Dokmetas I, Cevik M A, Dokuzoguz B, Tasyaran M A, Ozturk R, Bakir M, and Uzun R. 2009. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J Infect, 58: 238–244.PubMedCrossRefGoogle Scholar
- Hewson R, Chamberlain J, Mioulet V, Lloyd G, Jamil B, Hasan R, Gmyl A, Gmyl L, Smirnova S E, Lukashev A, Karganova G, and Clegg C. 2004. Crimean-Congo haemorrhagic fever virus: sequence analysis of the small RNA segments from a collection of viruses world wide. Virus Res, 102: 185–189.PubMedCrossRefGoogle Scholar
- Kubar A, Haciomeroglu M, Ozkul A, Bagriacik U, Akinci E, Sener K, and Bodur H. 2011. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis, 64: 439–443.PubMedGoogle Scholar
- Mourya D T, Yadav P D, Shete A M, Gurav Y K, Raut C G, Jadi R S, Pawar S D, Nichol S T, and Mishra A C. 2012. Detection, isolation and confirmation of Crimean-Congo hemorrhagic fever virus in human, ticks and animals in Ahmadabad, India, 2010–2011. PLoS Negl Trop Dis, 6: e1653.PubMedCrossRefGoogle Scholar
- Vanhomwegen J, Alves M J, Zupanc T A, Bino S, Chinikar S, Karlberg H, Korukluoglu G, Korva M, Mardani M, Mirazimi A, Mousavi M, Papa A, Saksida A, Sharifi-Mood B, Sidira P, Tsergouli K, Wolfel R, Zeller H, and Dubois P. 2012. Diagnostic assays for crimean-congo hemorrhagic fever. Emerg Infect Dis, 18: 1958–1965.PubMedCrossRefGoogle Scholar